AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
First publishedAug 3, 10:43 UTC
Last updatedAug 4, 08:49 UTC · 8m ago
1 outlet
MarketWatch
1 outlets over time — hover a bar for its window & outletslast updated
Answer
AstraZeneca shares were slumping while Bristol-Myers Squibb was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place.
Reported by 1 outlet — MarketWatch. See all sources ↓
Read the full report at MarketWatch ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
In brief
- What's the story?
- AstraZeneca shares were slumping while Bristol-Myers Squibb was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place.
- How widely is it covered?
- 1 outlet, average source rating 7.0/10.
- When was it last updated?
- 8m ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
Sources1TypeCoverage
Related in the knowledge graph
Sources (1)
Avg source rating 7.0/10Processing cluster
A1A2A3B1B2B3